• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, April 3, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

UIC awarded $22 million for translational research from NIH

Bioengineer by Bioengineer
July 16, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: UIC

The Center for Clinical and Translational Science, or CCTS, at the University of Illinois at Chicago will receive $22 million in new funding from the National Institutes of Health, or NIH, to continue its work supporting critical clinical and translational health research programs.

The center received initial funding in 2009 and over the last decade, it has helped provide multidisciplinary training and support to hundreds of faculty, researchers and staff at UIC who are involved in research that bridges the gap between scientific labs and patient care or community needs.

“The continued funding of the CCTS underscores UIC’s deep-rooted commitment to translational discovery that directly benefits our patients and communities,” said Dr. Robert Barish, vice chancellor for health affairs at UIC. “We are proud of this continued recognition and thankful for the investment in our interdisciplinary excellence across the university and its academic health enterprise.”

“Never has the value and need for clinical translational research been more evident and important as during the current COVID-19 pandemic, when teams of researchers have been pulling together to address the critical health needs of the population,” said Dr. Robin Mermelstein, co-director of the center and UIC professor of psychology. “The CCTS has been able to leverage vital institutional support from UIC to accelerate progress in moving discoveries into practice and policy and helping to develop opportunities and careers of faculty to address the health challenges we face.”

The new funding will be provided over five years.

The UIC center, which is part of the National Center for Advancing Translational Sciences’ Clinical and Translational Science Awards Program, is one of more than 50 centers in the U.S. to be funded as a hub of biomedical research.

It is one of the few research hubs to include research programs from seven health sciences colleges — including applied health sciences, dentistry, medicine, nursing, pharmacy, public health and social work — as well as other complementary UIC colleges, including engineering, liberal arts and sciences, and urban planning and public affairs.

According to the center’s directors, the breadth of potential collaborations across all of UIC’s 16 colleges is one of the strengths of the CCTS, which also is recognized for its attention to addressing health disparities and the needs of the Chicago community.

The center provides fundamental research services and tools — such as access to clinical data, informatics support, biostatistical support and consultation, data management tools, and training in community-based research collaborations — as well as mentoring and training. It also provides opportunities to develop innovative research addressing health issues through pilot funding, mentored career development and support for team science and interdisciplinary collaborations.

“The center provides support at every level of the research spectrum, from basic science through community engagement and implementation, and fosters collaborations between different disciplines with infrastructure, training, expertise and pilot funding as well as through conferences focused on critical research topics designed to bring researchers from all disciplines together,” said Dr. Richard Novak, co-director of the UIC Center for Clinical and Translational Science and UIC professor and head of infectious diseases.

Since 2009, UIC’s CCTS has provided more than $4 million in pilot funding to research projects across campus. Pilot funding has resulted in $54 million in subsequent external grant funding. Over 700 publications have cited CCTS support.

“With renewed funding, we look forward to continuing to help push clinical translational research forward rapidly so we can be most responsive to the complex needs of our communities,” Mermelstein said.

###

Media Contact
Jackie Carey
[email protected]

Original Source

https://today.uic.edu/uic-awarded-22m-for-translational-research-from-nih

Tags: Medicine/Health
Share13Tweet8Share2ShareShareShare2

Related Posts

Scientists Develop Injectable Particles to Enhance Safety in Infant Surgeries

April 3, 2026

New Study Uncovers How Calcium Channel Mutations Impact Early Brain Development in Childhood Epilepsy

April 3, 2026

iRGD-PLGA Nanocomplex Targets Colon Cancer Resistance

April 3, 2026

April 2026 APA Journals Spotlight New Research on Cannabis Use Disorder, Stigma Reduction, and Co-Occurring Mental Health Conditions

April 3, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    97 shares
    Share 39 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1008 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Toolpath Design Shapes Strength of 3D-Printed Glass

Scientists Develop Injectable Particles to Enhance Safety in Infant Surgeries

Mutant Clownfish Sheds Light on How Nature Defines Boundaries

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.